EMA backs renewing conditional marketing approval for remdesivir in COVID-19 patients - Reuters - 1 minute read
May 21 (Reuters) - Europe’s medicines regulator on Friday recommended to renew the conditional marketing authorization for Gilead Sciences’ remdesivir to treat COVID-19.
Reporting by Vishwadha Chander in Bengaluru; Editing by Anil D’Silva
Source: Reuters
Powered by NewsAPI.org